Skip to main content

Table 4 ANOVA for full model

From: Study of homogenization on media milling time in preparation of irbesartan nanosuspension and optimization using design of experiments (DoE)

Source of variation

DF

SS

MS

F

Significant F value

Ftab

Particle size (nm) (Y1)

Regression

5

54929.3

10985.9

706.23

8.4E−05

9.01

Residual

3

46.66

15.55

   

Total

8

54976

    

In vitro drug release at 10 min (Y2)

Regression

5

1054.40

210.88

86.34

0.0019

9.01

Residual

3

7.32

2.44

   

Total

8

1061.73